.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research identifies a significant link between uric acid osteoporosis risk. Scientists analyzed data from the 2015-2020 NHANES and conducted Mendelian randomization to understand how serum uric acid (SUA) influences bone health. Consequently, they found that higher SUA levels correlate with a reduced risk of osteoporosis.
The cross-sectional study included 6,020 participants. Individuals in the highest SUA quartiles showed a 49% lower risk compared to those in the lowest quartile. Furthermore, restricted cubic spline analysis revealed an L-shaped relationship. The study pinpointed a turning point at approximately 5.3 mg/dL. This suggests that maintaining moderate SUA levels might provide a protective effect against bone loss.
Subgroup analysis indicated that sex, race, and diabetes status are essential modifiers. Additionally, the Mendelian randomization analysis explored whether these findings represent a causal relationship. Although SUA is often associated with gout, its antioxidant properties may actually benefit bone metabolism. Therefore, physicians should consider these nuances when managing patients with metabolic disorders. Moreover, the study highlights the need for balanced clinical strategies regarding urate-lowering therapies.
Serum uric acid may act as an antioxidant in the blood. This helps protect bone mineral density and potentially reduces the risk of osteoporosis.
The study identified an L-shaped association. It showed a significant turning point around 5.3 mg/dL, where the risk of osteoporosis began to decrease significantly.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Liu QP et al. Association between serum uric acid levels and osteoporosis risk: evidence from a cross-sectional study and Mendelian randomization analysis. Clin Rheumatol. 2026 Feb 14. doi: 10.1007/s10067-026-07986-3. PMID: 41689734.
Wang H et al. Association of Serum Uric Acid Level With Bone Mineral Density and the Risk of Osteoporosis: A Dose-Response Meta-Analysis. Int J Rheum Dis. 2025 Jan 15. doi: 10.1111/1756-185X.70013. PMID: 39744825.
Song S et al. Value of serum uric acid in a risk prediction model for postmenopausal osteoporosis. Front Endocrinol (Lausanne). 2025 Aug 09;16:1434602. doi: 10.3389/fendo.2025.1434602.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A large-scale study reveals that higher serum uric acid levels are associated with a 49% lower risk of osteoporosis, suggesting a protective role in bone he...
8 months ago
Explore why official drug package inserts fail to reflect modern evidence for clozapine prescribing. Learn how legal standards of care, case law, slow titration, and vital adverse event monitoring empower clinicians to prioritize evidence-based medical practice over outdated manufacturer labeling.
Today
Occult maternal malignancy accounts for 3.82% of persistent unreportable NIPT results with genomic noise. Multiple chromosomal aberrations, notably on chromosome 18, warrant thorough oncological evaluation and whole-body MRI to ensure timely maternal diagnosis while preserving fetal care.
Today
This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today
A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
